Spina et al. (2016) correlated glioma patient survival with CHRNA gene expression using the Rembrandt portal1, and found that the survival of patients with gliomas or GBMs over-expressing CHRNA1 or CHRNA9 is significantly shorter. This evidence concerns the gene CHRNA1 and glioma.